Men's Health News

RSS

SARS-CoV-2 vaccines from Pfizer-BioNTech and AstraZeneca reduce mortality among the elderly

Researchers in the UK have demonstrated the efficacy of the Pfizer-BioNTech and AstraZeneca vaccines against severe acute respiratory virus coronavirus 2 (SARS-CoV-2) at preventing death among older individuals with coronavirus disease 2019 (COVID-19).

20 May 2021

Working conditions and non-workplace factors affect COVID-19 mortality in England

Researchers from England recently estimated occupational variations in COVID-19 mortality in England and Wales during 2020 and examined how these differences changed post adjustment for non-workplace factors.

19 May 2021

COVID-19 public health interventions reduced other respiratory infections

Wearing masks and quarantining while sick has helped mitigate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An indirect benefit of these efforts appears to be a decrease in flu cases and other respiratory infections. New research led by Lisa G. Winston of the University of California, San Francisco, confirmed COVID-19 public health interventions helped decrease the number of airborne viruses.

18 May 2021

New focus on adverse impact of male factors in assisted reproductive treatments

The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction.

17 May 2021

Most COVID-19 patients have neurological symptoms

In a new study, published in the journal JAMA Network, University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19 found that neurological manifestations were prevalent among patients hospitalized with COVID-19. The patients were also at a higher risk of in-hospital mortality.

17 May 2021

Supercarriers: Just 2% of SARS-CoV-2 positive people carry 90% of the virus

A new study published in the Proceedings of the National Academy of Sciences shows that the vast majority of the viral load in a community at any given point is present in a very small minority of the infected population, underlining the vast differences in viral loads between individuals.

14 May 2021

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.

13 May 2021

Automated machine learning predicts male infertility based on Johnsen score

Infertility affects females and males equally. In male infertility, azoospermia (a medical condition with no sperm in semen) is a major problem that prevents a couple from having a child.

11 May 2021

Prevalence of SARS-CoV-2 antibodies in Germany

Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.

10 May 2021

Novel biomarker discovered to identify male COVID-19 patients at greatest risk for ICU admission

Researchers have discovered a novel biomarker to identify male COVID-19 patients most at risk for ICU admission.

7 May 2021

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.

7 May 2021

SARS-CoV-2 infection prolongs viral shedding and lymphocyte loss in patients with cancer

Patients with cancer have a more challenging time with infections while undergoing treatment — placing them as high-risk for severe COVID-19 illness and death. However, how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with cancer therapies remains poorly understood.

7 May 2021

Israeli study shows real-world efficacy of Pfizer-BioNTech’s COVID-19 vaccine

Researchers have conducted an analysis of nationwide surveillance data from Israel demonstrating the real-world effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

6 May 2021

Study reveals no negative effect of SARS-CoV-2 BNT162b2 vaccination on male fertility

Researchers analyzed the sperm parameters of males undergoing fertility treatment and found no effect from the BNT162b2 mRNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

4 May 2021

Study finds one-third of COVID-19 patients experience neurological symptoms

The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.

3 May 2021

Thousands of men to trial new home test kit for prostate cancer

Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH).

30 Apr 2021

When can we stop wearing face masks?

Global rollout of vaccines to prevent coronavirus disease 2019 (COVID-19) is underway, with nine different vaccines approved for distribution by different countries. With four vaccines approved for distribution in the U.S., as of April 30, 2021, 29.9% of the U.S. population has now been fully vaccinated against SARS-CoV-2.

30 Apr 2021

Study shows decline in prostate cancer diagnoses during the pandemic

During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

29 Apr 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.

29 Apr 2021

Men's Health News

SARS-CoV-2 vaccines from Pfizer-BioNTech and AstraZeneca reduce mortality among the elderly

Working conditions and non-workplace factors affect COVID-19 mortality in England

COVID-19 public health interventions reduced other respiratory infections

New focus on adverse impact of male factors in assisted reproductive treatments

Most COVID-19 patients have neurological symptoms

Supercarriers: Just 2% of SARS-CoV-2 positive people carry 90% of the virus

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Automated machine learning predicts male infertility based on Johnsen score

Prevalence of SARS-CoV-2 antibodies in Germany

Novel biomarker discovered to identify male COVID-19 patients at greatest risk for ICU admission

Study suggests new avenues for treating Black patients who disproportionately die of prostate cancer

SARS-CoV-2 infection prolongs viral shedding and lymphocyte loss in patients with cancer

Israeli study shows real-world efficacy of Pfizer-BioNTech’s COVID-19 vaccine

Study reveals no negative effect of SARS-CoV-2 BNT162b2 vaccination on male fertility

Study finds one-third of COVID-19 patients experience neurological symptoms

Thousands of men to trial new home test kit for prostate cancer

When can we stop wearing face masks?

Study shows decline in prostate cancer diagnoses during the pandemic

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News